MXCT vs ROST · rev $38.6M vs P/E 21, rev $21.13B
MaxCyte Inc (MXCT) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported ROST revenue for 2025-02-01 was $21.13B. Net income was $2.09B. Revenue was up 3.7% from 2024-02-03 to 2025-02-01. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
MXCT currently screens at market cap $124.3M. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the MXCT and ROST stock pages for the full models.
Not investment advice.